| Literature DB >> 28815110 |
Yanhui Liang1, Fusheng Wang1,2, Pengyue Zhang2, Joel H Saltz1, Daniel J Brat3, Jun Kong3.
Abstract
With the rapid advancement in large-throughput scanning technologies, digital pathology has emerged as platform with promise for diagnostic approaches, but also for high-throughput quantitative data extraction and analysis for translational research. Digital pathology and biomarker images are rich sources of information on tissue architecture, cell diversity and morphology, and molecular pathway activation. However, the understanding of disease in three-dimension (3D) has been hampered by their traditional two-dimension (2D) representations on histologic slides. In this paper, we propose a scalable image processing framework to quantitatively investigate 3D phenotypic and cell-specific molecular features from digital pathology and biomarker images in information- lossless 3D tissue space. We also develop a generalized 3D spatial data management framework with multi-level parallelism and provide a sustainable infrastructure for rapid spatial queries through scalable and efficient spatial data processing. The developed framework can facilitate biomedical research by efficiently processing large-scale, 3D pathology and in-situ biomarker imaging data.Entities:
Year: 2017 PMID: 28815110 PMCID: PMC5543358
Source DB: PubMed Journal: AMIA Jt Summits Transl Sci Proc
Figure 1:Overall architecture of 3D pathology image analysis and high performance spatial queries and analytics.
Figure 2:3D visualization of blood vessels and biomarker populations.
Figure 3:Workflow of two-way spatial join.
Figure 4:The 3D structure of a blood vessel with its skeleton. The yellow dots are its skeleton vertices.
Figure 5:3D inter-stain registration results on H&E and IHC slices. (A)2D registration results on IHC image (R-1) (left), H&E image (R) (middle) and IHC image (R+1) (right). (B)3D visualization and close-up views of inter-stain registration results on H&E and IHC images.
Figure 6:Biomarker detection result for vascular (left) and macrophage (right).
Figure 7:Spatial density estimation of CD31 for vascular biomarker. (a) The IHC slice (b) The detected biomarker (c) The 2D view of spatial density
Figure 8:The correlation between necrotic centers and spatial density of hypoxia biomarker.